Estrogen suppresses breast cancer proliferation through GPER / p38 MAPK axis during hypoxia. (5th December 2015)

• Record Type: Journal Article
• Authors: Sathya, S.; Sudhagar, S.; Lakshmi, B.S.
• Is Part Of: Molecular and cellular endocrinology. Volume 417(2015)
• Page Start: 200
• Page End: 210
• Publication Date: 2015-12-05
• Subjects: Estrogen -- Breast cancer -- Hypoxia -- Cell cycle -- GPER -- p38 MAPK -- p21; Endocrinology -- Periodicals; Molecular biology -- Periodicals; Cytology -- Periodicals; Endocrinology -- Periodicals; Hormones -- Periodicals; Endocrinologie -- Périodiques; Cytology; Endocrinology; Molecular biology; Periodicals; 573.4
• DOI: 10.1016/j.mce.2015.09.032
• Languages: English
• ISSNs: 0303-7207

Abstract

Abstract: Breast cancer cells frequently experience hypoxia which is associated with resistance to hormonal therapy and poor clinical prognosis, making it important to understand the function of estrogen under hypoxic condition. Here, we demonstrate that estrogen suppresses breast cancer cell growth under hypoxia, through inhibition at G1 /S phase of cell cycle, by elevation of p21 expression. The involvement of GPER in estrogen mediated growth arrest was elucidated using specific ligands and siRNA. Although, estrogen was observed to activate both p44/42 and p38 MAPK signaling, pharmacological inhibition and silencing of p38 MAPK abrogated the induction of p21 expression and growth arrest, during hypoxia. The involvement of estrogen induced ROS in the p38 MAPK mediated p21 expression and cell growth arrest was established by observing that scavenging of ROS by NAC abrogated p38 MAPK activation and p21 expression during hypoxia. In conclusion, Estrogen suppresses breast cancer growth by inhibiting G1 /S phase transition through GPER/ROS/p38 MAPK/p21 mediated signaling during hypoxic condition.